Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Emgality (Galcanezumab) in Breastmilk in Adult Women With Migraine

NCT06085144 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT06085144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06085144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Emgality (Galcanezumab) in Breastmilk in Adult Women With Migraine
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Recruiting
Start date
February 26, 2024
Completion date
April 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine